According to Cognitive Market Research, the Global Bioinformatics Services Market Size will be USD XX Billion in 2023 and is set to achieve a market size of USD XX Billion by the end of 2031 growing at a CAGR of XX% from 2024 to 2031.

• The global Bioinformatics services Market will expand significantly by XX% CAGR between 2024 and 2031.

• Based on technology, Because of the growing number of platform applications and the need for improved tools for drug development, the bioinformatics platforms segment dominated the market.

• In terms of service type, The sequencing services segment held the largest share and is anticipated to grow over the coming years

• Based on application, The genomic segment dominated the bioinformatics market

• Based on End-user, academic institutes and research centers segment hold the largest share.

• Based on speciality segment, The medical bioinformatics segment holds the large share and is anticipated to expand at a substantial CAGR during the forecast period.

• The North America region accounted for the highest market share in the Global Bioinformatics Services Market. CURRENT SCENARIO OF THE BIOINFORMATICS SERVICES

Driving Factors of the Bioinformatics Services Market

Expansive uses of bioinformatics across multiple sectors is propelling the market's growth.

Several industries, such as the food, bioremediation, agriculture, forensics, and consumer industries, are also using bioinformatics services to improve the quality of their products and supply chain processes. Companies in a variety of sectors are rapidly utilizing bioinformatics services such as data integration, manipulation, lead generation, data management, in silico analysis, and advanced knowledge discovery.

• Bioinformatics Approaches in Food Sciences

In order to meet the needs of food production, food processing, enhancing the quality and nutritional content of food sources, and many other areas, bioinformatics plays a significant role in forecasting and evaluating the intended and undesired impacts of microorganisms on food, genomes, and proteomics research. Furthermore, bioinformatics techniques can be applied to produce crops with high yields and resistance to disease, among other desirable qualities. Additionally, there are numerous databases with information about food, including its components, nutritional value, chemistry, and biology.

Genome Canada is proud to partner with five Institutes where there are five funding pools within this opportunity and Genome Canada is partnering on the Bioinformatics, Computational Biology and Health Data Sciences pool. (Source:https://genomecanada.ca/genome-canada-partners-with-cihr-to-launch-health-research-training-platform-2024-25/)

• Bioinformatics in agriculture

Bioinformatics is becoming more and more crucial in the gathering, storing, and processing of genomic data in the field of agricultural genomics, or agri-genomics. Generally referred to as agri-informatics, some of the various applications of bioinformatics tools and methods in agriculture focus on improving plant resistance against biotic and abiotic stressors as well as enhancing the nutritional quality in depleted soils. Beyond these uses, computer software-assisted gene discovery has enabled researchers to create focused strategies for seed quality enhancement, incorporate extra micronutrients into plants for improved human health, and create plants with phytoremediation potential.

India/UK-based Agri-Genomics startup, Piatrika Biosystems has raised $1.2 Million in a seed round led by Ankur Capital. The company is bringing sustainable seeds and agri chemicals to market faster and cheaper. The investment will be used to build a strong Product Development team, also for more profound research, and to accelerate the productionising and commercialization of MVP. (Source:https://pressroom.icrisat.org/agri-genomics-startup-piatrika-biosystems-raises-12-million-in-seed-funding-led-by-ankur-capital)

This expansion in the application areas of bioinformatics services is likely to drive the overall market growth. Bioinformatics services such as data integration, manipulation, lead discovery, data management, in silico analysis, and advanced knowledge discovery are increasingly being adopted by companies across various industries.&...

Bioinformatics Services Market size was valued at USD 11.1 Billion in 2023 and is projected to reach USD 3.58 Billion by 2031, growing at a CAGR of 15.06% from 2024-2031.

Bioinformatics Services Market: Definition/ Overview

Bioinformatics services cover a wide range of computational tools and methods for managing, analyzing, and interpreting biological data. These services enable the integration of data from domains such as genomics, proteomics, transcriptomics, and metabolomics to provide insights into biological systems. Drug discovery, customized medicine, gene sequencing, and biological data management are some of the most important applications of bioinformatics. Researchers and healthcare professionals use these services to analyze big datasets, detect disease markers, and develop tailored medicines, considerably improving the precision and efficiency of life science research.

Snapshot img

Bioinformatics Market Size 2024-2028

The bioinformatics market size is forecast to increase by USD 13.2 billion at a CAGR of 16.59% between 2023 and 2028. The market is experiencing significant growth due to the reduction in the cost of genetic sequencing and the development of sophisticated bioinformatics tools for next-generation sequencing (NGS). These advancements are enabling the identification and analysis of disease biomarkers, leading to the discovery of new therapeutic strategies. The market is also driven by the increasing demand for database development and management systems to store and analyze the vast amounts of data generated from NGS. Furthermore, the potential of gene therapy and drug development in treating various diseases is fueling the market growth. However, the shortage of trained laboratory professionals poses a challenge to the market, as the analysis of complex genomic data requires specialized expertise.

What will be the Size of the Bioinformatics Market During the Forecast Period?

To learn more about the bioinformatics market report, Request Free Sample

Bioinformatics is a rapidly growing market, driven by advancements in genome sequencing and NGS technologies. Precision medicine, which utilizes genomic information for personalized healthcare, is a key application area. The market is witnessing a significant decrease in equipment costs, making genomics instruments more accessible to researchers and healthcare providers. Transcriptomics, which focuses on the study of RNA, is another emerging field. Virus research is a significant application area, with a focus on transmission chains, public health control, and containment measures. Virus variability and vaccine development are major challenges, driving the need for advanced diagnostic methods. Key players in the market include Illumina and Eurofins Scientific.

Moreover, companies are making strides in addressing this challenge by providing comprehensive solutions for bioinformatics analysis and data management. Big data is another key trend in the market, with the use of advanced algorithms and machine learning techniques to extract valuable insights from genomic data. Overall, the market is poised for strong growth, driven by technological advancements, increasing demand for personalized medicine, and the potential to revolutionize disease diagnosis and treatment. In addition, these companies provide a range of services, from DNA and RNA sequencing to bioinformatics analysis and diagnostic testing. The market is expected to grow significantly due to the increasing demand for accurate and timely diagnostic methods and the ongoing research in the field of genomics and transcriptomics.

The bioinformatics market is expanding rapidly, driven by advancements in genomics data analysis, next-gen sequencing, and precision medicine. Cloud-based bioinformatics solutions and AI in bioinformatics are revolutionizing molecular diagnostics, drug discovery platforms, and protein analysis tools. The market emphasizes genomic data storage, personalized healthcare, and biomarker discovery. With bioinformatics software, computational biology, and integrative bioinformatics solutions, bioinformatics as a service plays a pivotal role in advancing modern healthcare.

Bioinformatics Market Segmentation

The bioinformatics market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Application

  Molecular phylogenetics
  Transcriptomic
  Proteomics
  Metabolomics


Product

  Platforms
  Tools
  Services


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France


  Asia



  Rest of World (ROW)

By Application Insights

The molecular phylogenetics segment is estimated to witness significant growth during the forecast period. Bioinformatics, a critical field in molecular biology, encompasses the application of computational tools and techniques to analyze biological data. One significant area within bioinformatics is molecular phylogenetics, which utilizes molecular data to explore evolutionary relationships among various species. This technique has transformed the biological landscape by offering more precise and comprehensive insights into the interconnections among living organisms. In the international market, molecular phylogenetics is a vital instrument in numerous research domains, such as clinical diagnostics, drug discovery, RNA-based therapeutics, and conservation biology. For instance, in the realm of viral research, molecular phylogenetics is extensively employed to examine the evolution of viruses.

In addition, by deciphering the molecular data of distinct strains of viruses, scientists can trace the origins and dissemination patterns of these pathoge

The Report Covers Global Bioinformatics Services Market Growth & Insights. The Market is Segmented by Products and Services (Knowledge Management Tools, Bioinformatics Platform, and Bioinformatics Services), Applications (Microbial Genome, Gene Engineering, Drug Development, Personalized Medicine, Omics, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The value is provided in (USD million) for the above segments.

Subtitle

"Synthetic protein dataset with sequences, physical properties, and functional classification for machine learning tasks."

Description

Introduction

This synthetic dataset was created to explore and develop machine learning models in bioinformatics. It contains 20,000 synthetic proteins, each with an amino acid sequence, calculated physicochemical properties, and a functional classification.

Columns Included

• ID_Protein: Unique identifier for each protein.
• Sequence: String of amino acids.
• Molecular_Weight: Molecular weight calculated from the sequence.
• Isoelectric_Point: Estimated isoelectric point based on the sequence composition.
• Hydrophobicity: Average hydrophobicity calculated from the sequence.
• Total_Charge: Sum of the charges of the amino acids in the sequence.
• Polar_Proportion: Percentage of polar amino acids in the sequence.
• Nonpolar_Proportion: Percentage of nonpolar amino acids in the sequence.
• Sequence_Length: Total number of amino acids in the sequence.
• Class: The functional class of the protein, one of five categories: Enzyme, Transport, Structural, Receptor, Other.

Inspiration and Sources

While this is a simulated dataset, it was inspired by patterns observed in real protein datasets, such as: - UniProt: A comprehensive database of protein sequences and annotations. - Kyte-Doolittle Scale: Calculations of hydrophobicity. - Biopython: A tool for analyzing biological sequences.

Proposed Uses

This dataset is ideal for: - Training classification models for proteins. - Exploratory analysis of physicochemical properties of proteins. - Building machine learning pipelines in bioinformatics.

How This Dataset Was Created

1. Sequence Generation: Amino acid chains were randomly generated with lengths between 50 and 300 residues.
2. Property Calculation: Physicochemical properties were calculated using the Biopython library.
3. Class Assignment: Classes were randomly assigned for classification purposes.

Limitations

• The sequences and properties do not represent real proteins but follow patterns observed in natural proteins.
• The functional classes are simulated and do not correspond to actual biological characteristics.

Data Split

The dataset is divided into two subsets: - Training: 16,000 samples (proteinas_train.csv). - Testing: 4,000 samples (proteinas_test.csv).

Acknowledgment

This dataset was inspired by real bioinformatics challenges and designed to help researchers and developers explore machine learning applications in protein analysis.

The application of project-based learning in bioinformatics training

The global bioinformatics market size reached USD 13.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.4 Billion by 2033, exhibiting a growth rate (CAGR) of 11.69% during 2025-2033. Rapid technological advancements, increasing genomic sequencing, surging demand for personalized medicine, data analytics growth, investment in research and development (R&D), expanding biological databases, and the rising focus on preventive care are some of the factors fostering the market growth.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on the product and service, application, and end-use sector.

The market size of the Bioinformatics Services Market is categorized based on Application (Genomic Data Analysis, Biological Data Management) and Product (Research, Clinical Applications) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

This report provides insights into the market size and forecasts the value of the market, expressed in USD million, across these defined segments.

The Global Bioinformatics Market is expected to reach at a CAGR 12.8% during the forecast period (2024-2031).| DataM Intelligence

Bioinformatics, the application of computational tools to the management and analysis of biological data, has stimulated rapid research advances in genomics through the development of data archives such as GenBank, and similar progress is just beginning within ecology. One reason for the belated adoption of informatics approaches in ecology is the breadth of ecologically pertinent data (from genes to the biosphere) and its highly heterogeneous nature. The variety of formats, logical structures, and sampling methods in ecology create significant challenges. Cultural barriers further impede progress, especially for the creation and adoption of data standards. Here we describe informatics frameworks for ecology, from subject-specific data warehouses, to generic data collections that use detailed metadata descriptions and formal ontologies to catalog and cross-reference information. Combining these approaches with automated data integration techniques and scientific workflow systems will maximize the value of data and open new frontiers for research in ecology.

The Personalized Medicine Bioinformatics Market Report is Segmented by Technology (Gene Sequencing, Pharmacogenomics, Microarray Technology, Others), Application (Genomics, Proteomics, Transcriptomics, Others), End User (Biotechnology and Pharmaceutical Companies, Hospitals, Others), and Geography (North America, Europe, Asia-Pacific, and the Rest of the World). The Report Offers the Value (in USD) for the Above Segments.

This dataset is about book subjects and is filtered where the books includes Computational intelligence and big data analytics : applications in bioinformatics, featuring 10 columns including authors, average publication date, book publishers, book subject, and books. The preview is ordered by number of books (descending).

An example of customized R code generated by iDEP. This code is generated for the analysis of the Hoxa1 dataset. (R 11 kb)

Tables S1-S16. Table S1. contains list of 220 species covered by current version of iDEP. Table S2. include the 2196 types of gene IDs that can be recognized. Tables S3-S16. are results from the analyses of two example datasets. (XLSX 1970 kb)

Explore BCC Research's comprehensive report on Bioinformatics technologies Market. This report aims to study current and historical market revenues can be estimated based on the services & platforms, solutions, and application type.

The Bioinformatics Services Market Report is Segmented by Service Type (Data Analysis, Database Management, Sequencing, and Others), by Application (Drug Design, Genomics & Proteomics, Metabolomics, Transcriptomics, and Others), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organization, Academic Institutes & Research Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (in USD) for the Above Segments.

The Forensic Genetics Bioinformatics Market is Segmented by Application (Criminal Investigation, Paternity Testing, Disaster Victim Identification, and Others), Technology (DNA Sequencing, Data Analysis Software, and Bioinformatics Tools), End User (Forensic Laboratories, Law Enforcement Agencies, and Research Institutes), and Geography (North America, Europe, Asia-Pacific, and Middle East and Africa and South America). The Report Offers the Value (in USD) for the Above Segments.

United States bioinformatics market size is projected to exhibit a growth rate (CAGR) of 14.50% during 2024-2032. The recent advancements in sequencing technologies, shifting trend towards personalized medicine in healthcare, increasing establishment of biobanks, rising government fundings and initiatives, and the integration of artificial intelligence (AI) represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product and service, application, and end use sector.

Introduction

The Global Bioinformatics Services Market is poised for substantial growth, projected to increase from USD 2.9 billion in 2023 to USD 10.7 billion by 2033, achieving a compound annual growth rate (CAGR) of 13.9%. This market expansion is fueled by several key factors including technological advancements in genomics and the increasing complexity of biological datasets, which necessitate advanced computational technologies for efficient data management, analysis, and interpretation. These technologies are crucial for advancing medical research and improving patient care, particularly through personalized treatment plans and precision medicine.

Institutions like the Mayo Clinic are significantly contributing to this growth by expanding their bioinformatics services to support translational research and enhance patient care through the integration of large multi-omics data sets. Additionally, prominent educational institutions such as Stanford and Georgetown University are advancing their bioinformatics programs to equip the next generation of professionals with the necessary skills to address complex biomedical challenges using computational and quantitative methods.

The sector is also witnessing a surge in demand within the healthcare and pharmaceutical industries, where bioinformatics tools are integral to drug discovery and disease diagnosis. This demand drives the development of therapeutic strategies and deepens the understanding of disease mechanisms, further boosting the market growth. Research initiatives and collaborations, such as those at Harvard Medical School’s Department of Biomedical Informatics and Stanford's Biomedical Informatics Research division, are key in transforming biomedical data into actionable insights for precision medicine.

In terms of recent industry developments, in January 2024, Qiagen announced a significant expansion of investments into its Qiagen Digital Insights (QDI) business. This expansion, fueled by robust sales of approximately $100 million in 2023, is set to enhance QDI's bioinformatics capabilities, including launching at least five new products and broadening the applications of Artificial Intelligence and Natural Language Processing within the sector.

Furthermore, in January 2023, Agilent Technologies unveiled a major investment of $725 million to double its manufacturing capacity for nucleic acid-based therapeutics, in response to the rapid growth in the therapeutic oligonucleotides market, projected to reach $2.4 billion by 2027. This expansion will introduce two new manufacturing lines to meet the escalating demand for siRNA, antisense, and CRISPR guide RNA molecules, reinforcing Agilent's market presence and capacity in this fast-evolving field.

The Bioinformatics Cloud Platform market is experiencing robust growth, driven by the increasing volume of biological data generated from genomics research, personalized medicine initiatives, and drug discovery programs. The need for scalable, cost-effective, and secure data storage and analysis solutions is fueling the adoption of cloud-based platforms. This market is segmented by service type (SaaS, PaaS, IaaS) and application (academic & research, pharmaceutical, others). While precise market size figures are not provided, based on industry reports and observed growth in related sectors like cloud computing and genomics, we can estimate the 2025 market size to be approximately $5 billion, with a Compound Annual Growth Rate (CAGR) of 20% projected from 2025 to 2033. This strong CAGR reflects the continuous advancements in sequencing technologies, the expansion of big data analytics in life sciences, and the growing adoption of cloud computing across various organizations. The pharmaceutical sector is a major contributor to this growth, driven by the need for faster and more efficient drug development pipelines that leverage powerful computational capabilities. Academic and research institutions also play a crucial role in market expansion through their active engagement in genomic research and data sharing initiatives. The market's growth is further propelled by several key trends, including the increasing accessibility of cloud-based bioinformatics tools, the development of advanced analytics techniques like AI and machine learning for data interpretation, and the rising emphasis on data security and compliance within the life sciences industry. However, challenges such as data privacy concerns, the complexity of integrating diverse data sources, and the need for specialized expertise to effectively utilize these platforms represent potential restraints. Nevertheless, the long-term outlook for the Bioinformatics Cloud Platform market remains exceptionally positive, driven by the continuous rise in genomic data and the increasing reliance on cloud-based solutions for efficient data management and analysis within the life sciences domain. Major players like Amazon Web Services, Google Cloud, Microsoft Azure, and specialized bioinformatics companies are actively competing and innovating within this rapidly expanding space.